S. W. Lawrence, MD·Sep 23, 2024HIV Prophylaxis in At-risk MenAAAS: “Shots prevent HIV in at-risk men.” A new milestone in public health: “A drug injected just twice a year has demonstrated a…
Michael Saei·Sep 10, 2020Gilead Sciences Renews Support of PARS Equality CenterMichael Saei, president of First Financial Capital in Los Angeles, is a supporter of the PARS Equality Center. In 2019, Michael Saei…
Sherry AN·Aug 27, 2020Is Gilead ($GILD) Stock a buy at $65?Recently Gilead Science has been in hot discussion, due to it’s medicine Remdesivir helped Covid-19 patients from recovering. But recently…
Divya Guha·Jul 4, 2020Indian media’s hustle for Big Pharma bares conflicts of interestSome media outlets sold propaganda for remdesivir. Hindustan Times peddled a drug its owners have a commercial interest in.
Rashmee Roshan Lall·Jul 3, 2020The moral case for the world to have access to covid-19 drugAs someone with a vested interest in Gilead Sciences, the company that makes the covid-19 drug remdesivir, I’m looking for a return on…
